Deficient activation of CD95 (APO-1/Fas)-mediated apoptosis: a potential factor of multidrug resistance in human renal cell carcinoma.
about
Analysis of Fas gene mutations on laser capture microdissected specimens from renal cell carcinoma.Bleomycin and the skin.Apoptosis induction in renal cell carcinoma by TRAIL and gamma-radiation is impaired by deficient caspase-9 cleavage.Disturbed balance of expression between XIAP and Smac/DIABLO during tumour progression in renal cell carcinomas.Resistance to Targeted Therapies in Renal Cancer: The Importance of Changing the Mechanism of Action.Downregulation of Bcl-2 sensitises interferon-resistant renal cancer cells to Fas.Loss of drug-induced activation of the CD95 apoptotic pathway in a cisplatin-resistant testicular germ cell tumor cell line.
P2860
Q31119899-42A9C1FC-559D-4687-B188-067E4B9D0A42Q36620749-E021B577-C615-4671-87CB-9B7D3FB14E8DQ38309197-C3060AC2-6AB6-4D1D-92A9-4ABBF38AA1CAQ38801768-EDAE0623-F305-4B13-917D-51D92F513B43Q39008859-EC2EF86D-A5FC-4D5B-876C-88443251CDD7Q42143671-4342BA77-C9B6-479E-AADB-4AB7D2678785Q53926583-B66A1F49-6630-4E67-8506-D831640A178E
P2860
Deficient activation of CD95 (APO-1/Fas)-mediated apoptosis: a potential factor of multidrug resistance in human renal cell carcinoma.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Deficient activation of CD95 ( ...... in human renal cell carcinoma.
@en
type
label
Deficient activation of CD95 ( ...... in human renal cell carcinoma.
@en
prefLabel
Deficient activation of CD95 ( ...... in human renal cell carcinoma.
@en
P2093
P2860
P356
P1476
Deficient activation of CD95 ( ...... in human renal cell carcinoma.
@en
P2093
Czarnotta B
Gabbert HE
Gerharz CD
Kalinski T
P2860
P2888
P304
P356
10.1054/BJOC.2000.1155
P407
P577
2000-06-01T00:00:00Z
P5875
P6179
1034055341